Therefore, inclusion of screening and counselling for depression within routine antenatal care (ANC) and prevention of mother-to-child transmission (PMTCT) services could be a particularly effective intervention, especially as the WHO has recently suggested an expansion in ART eligibility to include all HIV infected individuals regardless of their CD4 cell count or clinical disease staging [46]. This evidence concerns the gene CD4 and major depressive disorder.